PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAbCellera Biologics
AbCellera Biologics(ABCL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Etesevimab
covid-19
,
severe acute respiratory syndrome-related coronavirus
Bamlanivimab
covid-19
,
severe acute respiratory syndrome-related coronavirus
Bevifimod
sickle cell anemia
,
neoplasms
,
colonic neoplasms
,
adenocarcinoma
,
systemic lupus erythematosus
,
colorectal neoplasms
,
agammaglobulinemia
,
primary immunodeficiency diseases
,
von willebrand diseases
,
alzheimer disease
,
graft vs host disease
,
thrombocytopenic purpura idiopathic
,
protein c deficiency
,
leukemia
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
hodgkin disease
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
myeloid leukemia chronic-phase
,
large b-cell lymphoma diffuse
,
myeloid leukemia accelerated phase
,
burkitt lymphoma
,
large-cell lymphoma immunoblastic
,
hemophilia b
,
thrombotic thrombocytopenic purpura
,
chronic obstructive pulmonary disease
,
dementia
,
mucocutaneous lymph node syndrome
,
immunologic deficiency syndromes
,
hemophilia a
,
alpha 1-antitrypsin deficiency
,
disease
,
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use